CB1 receptor expression and signaling are required for dexamethasone-induced aversive memory consolidation.
Aversive memory
CB1 KO mice
Cannabinoids
Glucocorticoids
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
15 11 2023
15 11 2023
Historique:
received:
14
12
2022
revised:
12
07
2023
accepted:
27
07
2023
medline:
6
9
2023
pubmed:
5
8
2023
entrez:
4
8
2023
Statut:
ppublish
Résumé
The molecular processes that underlie long-term memory formation involve signaling pathway activation by neurotransmitter release, which induces the expression of immediate early genes, such as Zif268, having a key role in memory formation. In this work, we show that the cannabinoid CB1 receptor signaling is necessary for the effects of dexamethasone on the behavioral response in an inhibitory avoidance task, on dexamethasone-induced ERK phosphorylation, and on dexamethasone-dependent Zif268 expression. Furthermore, we provide primary evidence for the mechanism responsible for this crosstalk between cannabinoid and glucocorticoid-mediated signaling pathways, showing that dexamethasone regulates endocannabinoid metabolism by inhibiting the activity of the Fatty acid amide hydrolase (FAAH), an integral membrane enzyme that hydrolyzes endocannabinoids and related amidated signaling lipids. Our results provide novel evidence regarding the role of the endocannabinoid system, and in particular of the CB1 receptor, as a mediator of the effects of glucocorticoids on the consolidation of aversive memories.
Identifiants
pubmed: 37541383
pii: S0028-3908(23)00264-2
doi: 10.1016/j.neuropharm.2023.109674
pii:
doi:
Substances chimiques
Endocannabinoids
0
Receptor, Cannabinoid, CB1
0
Cannabinoids
0
Glucocorticoids
0
Dexamethasone
7S5I7G3JQL
Amidohydrolases
EC 3.5.-
Cannabinoid Receptor Modulators
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
109674Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest None.